ARQ-151 cream 0.15%
Sponsors
Arcutis Biotherapeutics, Inc.
Conditions
Atopic Dermatitis (Eczema)Psoriasis
Phase 1
Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis
CompletedNCT03392168
Start: 2017-12-11End: 2018-05-02Updated: 2022-08-04
Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema
CompletedNCT04156191
Start: 2019-12-23End: 2023-05-02Updated: 2023-07-24